4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-23-003462
Options or other derivatives
- CFO acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| NAGASAKI YASUSHI CFO | 2023-01-12 | Grant or award · Options | +150,000 | $4.50 | $675,000 | 150,000 | D |
Loading xslF345X03/doc4.xml…